Cargando…

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications

Polycystic ovary syndrome (PCOS) is often accompanied with metabolic disturbances attributed to androgen excess and obesity, but the contribution of each has not been defined, and the occurrence of metabolic disturbances is usually not investigated. Ninety-nine women with PCOS and forty-one without...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Alarcón, Mardia, Vital-Reyes, Víctor Saúl, Almeida-Gutiérrez, Eduardo, Maldonado-Hernández, Jorge, Flores-Chávez, Salvador, Domínguez-Salgado, Juan Manuel, Vite-Bautista, José, Cruz-Martínez, David, Barradas-Vázquez, Aly S., Z’Cruz-López, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533085/ https://www.ncbi.nlm.nih.gov/pubmed/37763087 http://dx.doi.org/10.3390/jpm13091319

Ejemplares similares

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
por: Abdalqader, Manal Madany, et al.
Publicado: (2020)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls
por: Chappell, Neil Ryan, et al.
Publicado: (2020)

Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome
por: Harris, R. Alan, et al.
Publicado: (2023)

Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Shan, Chang, et al.
Publicado: (2022)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor
por: Roozbeh, Jamshid, et al.
Publicado: (2022)

Diagnosis of Sertoli-Leydig Cell Tumor of the Ovary Complicated by the Pattern of Hyperandrogenemia and Results of Imaging
por: Jaju, Amruta, et al.
Publicado: (2021)

Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain
por: Golbahar, Jamal, et al.
Publicado: (2012)

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
por: Ozegowska, Katarzyna, et al.
Publicado: (2020)

Adrenal myelolipoma with hyperandrogenemia and schizophrenia
por: Liu, Ningning, et al.
Publicado: (2018)

Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report
por: Adefris, Mulat, et al.
Publicado: (2017)

Hyperandrogenemia due to ingestion of Butea superba
por: Chaiyasit, Kamon, et al.
Publicado: (2012)

The impact of obesity on hyperandrogenemia in Korean girls
por: Kang, Min Jae, et al.
Publicado: (2016)

Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome
por: YETİM ŞAHİN, Aylin, et al.
Publicado: (2019)

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue
por: Zhang, Yahui, et al.
Publicado: (2023)

Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
por: Dadachanji, Roshan, et al.
Publicado: (2018)

Postmenopausal women with hyperandrogenemia: Three case reports
por: Zhu, Xiao-Dan, et al.
Publicado: (2021)

Cardiometabolic consequences of maternal hyperandrogenemia in male offspring
por: Zuchowski, Yvonne, et al.
Publicado: (2021)

Manejo de la obesidad en niños y adolescentes
por: López-Alarcón, Mardia Guadalupe
Publicado: (2022)

Hair cortisol in polycystic ovary syndrome
por: Gonzalez, D., et al.
Publicado: (2022)

The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
por: Valderhaug, T.G., et al.
Publicado: (2015)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Lipid Profile in Adolescent Girls with Type 1 Diabetes Mellitus and Hyperandrogenemia
por: Zachurzok, Agnieszka, et al.
Publicado: (2016)

Testosterone/Epitestosterone Ratios—Further Hints to Explain Hyperandrogenemia in Children with Autism
por: Gasser, Benedikt, et al.
Publicado: (2021)

THU650 Prevalence Of Hyperandrogenemia, PCOS And Obesity In Mothers Of Daughters With PCOS
por: Cai, Jie, et al.
Publicado: (2023)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

The Effect of Metformin and Carbohydrate-Controlled Diet on DNA Methylation and Gene Expression in the Endometrium of Women with Polycystic Ovary Syndrome
por: García-Gómez, Elizabeth, et al.
Publicado: (2023)

Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age
por: Maldonado, Stephanie S., et al.
Publicado: (2022)

Participation of the Cholinergic System in the Development of Polycystic Ovary Syndrome
por: Linares, Rosa, et al.
Publicado: (2021)

Obesity Is Associated with Changes in Iron Nutrition Status and Its Homeostatic Regulation in Pregnancy
por: Flores-Quijano, María Eugenia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3778cmmito8ilj148ed32pf8kn